AstraZeneca_NN
Annual_JJ
Report_NN
and_CC
126_CD
Form_NN
20-F_JJ
Information_NOMZ
2005_CD
NOTES_NN
TO_PIN
THE_DT
FINANCIAL_NN
STATEMENTS_NOMZ
CONTINUED_VBD
25_CD
COMMITMENTS_NOMZ
AND_CC
CONTINGENT_JJ
LIABILITIES_NOMZ
CONTINUED_VBD
General_NN
With_PIN
respect_NN
to_PIN
each_QUAN
of_PIN
the_DT
legal_JJ
proceedings_GER
described_VBN
above_PLACE
,_,
other_JJ
than_PIN
those_DEMP
which_WDT
have_VPRT [PEAS]
been_VBN [PASS]
disposed_VBN
of_PIN [STPR]
,_,
we_FPP1
are_VPRT [BEMA]
unable_PRED
to_TO
make_VB
estimates_NN
of_PIN
the_DT
loss_NN
or_CC
range_NN
of_PIN
losses_NN
at_PIN
this_DEMO
stage_NN
,_,
other_JJ
than_PIN
where_RB
noted_VBN [PRIV]
in_PIN
the_DT
case_NN
of_PIN
the_DT
European_JJ
Commission_NN
fine_NN
._.
We_FPP1
also_RB
do_VPRT
not_XX0
believe_VB [PRIV]
that_THVC
disclosure_NN
of_PIN
the_DT
amount_NN
sought_VBN [WZPAST]
by_PIN
plaintiffs_NN
,_,
if_COND
that_DEMP
is_VPRT [PASS]
known_VBN [PRIV]
,_,
would_PRMD
be_VB [BEMA]
meaningful_PRED
with_PIN
respect_NN
to_PIN
those_DEMO
legal_JJ
proceedings_GER
._.
This_DEMP
is_VPRT [BEMA]
due_PRED
to_PIN
a_DT
number_NN
of_PIN
factors_NN
including_VBG [WZPRES]
:_:
the_DT
stage_NN
of_PIN
the_DT
proceedings_GER
in_PIN
many_QUAN
cases_NN
trial_NN
dates_NN
have_VPRT [PEAS]
not_XX0
been_VBN [PASS]
set_VBN
and_CC
overall_JJ
length_NN
and_PHC
extent_NN
of_PIN
legal_JJ
discovery_NN
:_:
the_DT
entitlement_NOMZ
of_PIN
the_DT
parties_NN
to_PIN
an_DT
action_NOMZ
to_TO
appeal_VB
a_DT
decision_NN
:_:
clarity_NOMZ
as_IN
to_PIN
theories_NN
of_PIN
liability_NOMZ
:_:
damages_NN
and_CC
governing_VBG
law_NN
:_:
uncertainties_NN
in_PIN
timing_NN
of_PIN
litigation_NOMZ
:_:
and_ANDC
the_DT
possible_JJ
need_NN
for_PIN
further_JJ
legal_JJ
proceedings_GER
to_TO
establish_VB [PRIV]
the_DT
appropriate_JJ
amount_NN
of_PIN
damages_NN
,_,
if_COND
any_QUAN
._.
However_CONJ
,_,
although_CONC
there_EX
can_POMD
be_VB
no_SYNE
assurance_NN
regarding_VBG [WZPRES]
the_DT
outcome_NN
of_PIN
any_QUAN
of_PIN
the_DT
legal_JJ
proceedings_GER
or_CC
investigations_NOMZ
referred_VBD
to_PIN
in_PIN
this_DEMO
Note_NN
25_CD
to_PIN
the_DT
Financial_NN
Statements_NOMZ
,_,
we_FPP1
do_VPRT
not_XX0
expect_VB [PRIV]
them_TPP3
to_TO
have_VB
a_DT
materially_RB
adverse_JJ
effect_NN
on_PIN
our_FPP1
financial_JJ
position_NOMZ
or_CC
profitability_NOMZ
._.
Taxation_NOMZ
Where_RB
tax_NN
exposures_NN
can_POMD
be_VB [PASS]
quantified_VBN
,_,
a_DT
provision_NN
is_VPRT [PASS]
made_VBN
based_VBN
on_PIN
best_JJ
estimates_NN
and_PHC
managements_NOMZ
judgement_NOMZ
._.
Details_NN
of_PIN
the_DT
movements_NOMZ
in_PIN
relation_NOMZ
to_PIN
material_JJ
tax_NN
exposures_NN
are_VPRT [PASS]
discussed_VBN
below_PLACE
._.
AstraZeneca_NN
had_VBD [PEAS]
made_VBN
certain_JJ
double_JJ
taxation_NOMZ
relief_NN
claims_NN
in_PIN
accordance_NN
with_PIN
its_PIT
understanding_GER
of_PIN
existing_VBG
law_NN
._.
Management_NOMZ
estimated_VBD [PRIV]
that_THVC
the_DT
tax_NN
exposure_NN
as_IN
at_PIN
31_CD
December_NN
2004_CD
in_PIN
respect_NN
of_PIN
the_DT
issue_NN
was_VBD
$_$
197m_CD
and_CC
the_DT
potential_NN
for_PIN
additional_JJ
losses_NN
above_PLACE
and_CC
beyond_IN
the_DT
amount_NN
provided_VBD
was_VBD
up_RB
to_TO
$_$
130m_CD
,_,
although_CONC
considered_VBN [PRIV]
that_THVC
these_DEMO
additional_JJ
losses_NN
were_VBD [BEMA]
unlikely_PRED
to_TO
arise_VB
._.
It_PIT
was_VBD [SPAU] [PASS]
also_RB
reported_VBN [PUBV]
as_IN
at_PIN
31_CD
December_NN
2004_CD
that_DEMO
AstraZeneca_NN
expected_VBD [PRIV]
a_DT
definitive_JJ
ruling_NN
on_PIN
the_DT
matter_NN
within_PIN
the_DT
next_JJ
12_CD
months_NN
._.
During_PIN
the_DT
course_NN
of_PIN
2005_CD
,_,
the_DT
relevant_JJ
law_NN
on_PIN
the_DT
availability_NOMZ
of_PIN
credit_NN
for_PIN
foreign_JJ
taxes_NN
was_VBD [PASS]
clarified_VBN
,_,
confirming_VBG [PUBV]
that_THVC
tax_NN
credits_NN
were_VBD
to_TO
be_VB [PASS]
allowed_VBN [SUAV]
in_PIN
accordance_NN
with_PIN
the_DT
original_JJ
claims_NN
made_VBN [WZPAST]
by_PIN
AstraZeneca_NN
and_CC
with_PIN
retrospective_JJ
effect_NN
._.
The_DT
Company_NN
has_VPRT [SPAU] [PEAS]
consequently_CONJ
released_VBN
this_DEMO
provision_NN
of_PIN
$_$
197m_CD
to_PIN
the_DT
income_NN
statement_NOMZ
._.
AstraZeneca_NN
faces_VPRT
a_DT
number_NN
of_PIN
transfer_NN
pricing_GER
audits_NN
in_PIN
jurisdictions_NOMZ
around_PLACE
the_DT
world_NN
._.
The_DT
issues_NN
under_IN
audit_NN
are_VPRT [BEMA]
often_RB
complex_PRED
and_CC
can_POMD
require_VB [SUAV]
many_QUAN
years_NN
to_TO
resolve_VB [SUAV]
._.
Accruals_NN
for_PIN
tax_NN
contingencies_NN
require_VPRT [SUAV]
management_NOMZ
to_TO
make_VB
estimates_NN
and_PHC
judgements_NOMZ
with_PIN
respect_NN
to_PIN
the_DT
ultimate_JJ
outcome_NN
of_PIN
a_DT
tax_NN
audit_NN
,_,
and_ANDC
actual_JJ
results_NN
could_POMD
vary_VB
from_PIN
these_DEMO
estimates_NN
._.
The_DT
total_JJ
accrual_NN
included_VBD
in_PIN
the_DT
Financial_NN
Statements_NOMZ
to_TO
cover_VB
the_DT
worldwide_JJ
exposure_NN
to_TO
transfer_VB
pricing_GER
audits_NN
is_VPRT
$_$
543m_CD
,_,
an_DT
increase_NN
of_PIN
$_$
143m_CD
due_JJ
to_PIN
a_DT
number_NN
of_PIN
new_JJ
audits_NN
and_PHC
revisions_NN
of_PIN
estimates_NN
relating_VBG [WZPRES]
to_TO
existing_VBG
audits_NN
._.
For_PIN
certain_JJ
of_PIN
the_DT
audits_NN
,_,
AstraZeneca_NN
estimates_VPRT [PRIV]
the_DT
potential_NN
for_PIN
additional_JJ
losses_NN
above_PLACE
and_CC
beyond_IN
the_DT
amount_NN
provided_VBN
to_TO
be_VB
up_RB
to_TO
$_$
190m_CD
:_:
however_CONJ
,_,
management_NOMZ
believes_VPRT [PRIV]
that_THVC
it_PIT
is_VPRT [BEMA]
unlikely_PRED
that_THAC
these_DEMO
additional_JJ
losses_NN
will_PRMD
arise_VB
._.
Of_PIN
the_DT
remaining_VBG
tax_NN
exposures_NN
,_,
the_DT
Company_NN
does_VPRT
not_XX0
expect_VB [PRIV]
material_NN
additional_JJ
losses_NN
._.
It_PIT
is_VPRT [BEMA]
not_XX0
possible_PRED
to_TO
estimate_VB [PRIV]
the_DT
timing_NN
of_PIN
tax_NN
cash_NN
flows_VPRT
in_PIN
relation_NOMZ
to_PIN
each_QUAN
outcome_NN
._.
Included_VBN [PASTP]
in_PIN
the_DT
provision_NN
is_VPRT [BEMA]
an_DT
amount_NN
of_PIN
interest_NN
of_PIN
$_$
174m_CD
._.
Interest_NN
is_VPRT [PASS]
accrued_VBN
as_IN
a_DT
tax_NN
expense_NN
._.
26_CD
LEASES_NN
Total_NN
rentals_NN
under_IN
operating_VBG
leases_NN
charged_VBN [WZPAST]
to_PIN
the_DT
income_NN
statement_NOMZ
were_VBD
as_IN
follows_VPRT
:_:
2005 2004 2003_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD [BEMA]
155_CD
127_CD
94_CD
The_DT
future_NN
minimum_NN
lease_NN
payments_NOMZ
under_IN
operating_VBG
leases_NN
that_TSUB
have_VPRT
initial_JJ
or_CC
remaining_VBG
terms_NN
in_PIN
excess_NN
of_PIN
one_CD
year_NN
at_PIN
31_CD
December_NN
2005_CD
were_VBD
as_IN
follows_VPRT
:_:
Operating_VBG
leases_NN
2005 2004 2003_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Obligations_NOMZ
under_IN
leases_NN
comprise_VPRT
Rentals_NN
due_JJ
within_PIN
one_CD
year_NN
83 112 112_CD
Rentals_NN
due_JJ
after_IN
more_EMPH
than_PIN
one_CD
year_NN
:_:
After_IN
five_CD
years_NN
90_CD
69_CD
80_CD
From_PIN
four_CD
to_PIN
five_CD
years_NN
18_CD
28_CD
25_CD
From_PIN
three_CD
to_PIN
four_CD
years_NN
26_CD
35_CD
28_CD
From_PIN
two_CD
to_PIN
three_CD
years_NN
41_CD
45_CD
40_CD
From_PIN
one_CD
to_PIN
two_CD
years_NN
52_CD
63 56 227 240_CD
229 310 352 341_CD
